CAMP4 Therapeutics Corporation Common Stock (CAMP) is a publicly traded Healthcare sector company. As of July 27, 2026, CAMP trades at $3.32 with a market cap of $164.09M and a P/E ratio of -1.34. CAMP moved +5.06% today. Year to date, CAMP is -46.35%; over the trailing twelve months it is +64.58%. Its 52-week range spans $1.31 to $10.80. Analyst consensus is strong buy with an average price target of $8.50. Rallies surfaces CAMP's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
CAMP4 Therapeutics Corporation Common Stock (CAMP) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. CAMP moved +5.06% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $3.32 |
| Market Cap | $164.09M |
| P/E Ratio | -1.34 |
| EPS | $-2.36 |
| Dividend Yield | 0.00% |
| 52-Week High | $10.80 |
| 52-Week Low | $1.31 |
| Volume | 155 |
| Avg Volume | 0 |
| Revenue (TTM) | $3.93M |
| Net Income | $-86.30M |
| Gross Margin | 0.00% |
6 analysts cover CAMP: 0 strong buy, 6 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $8.50.